CAEH Financials 07/15/2014 21:27:14 Caleco Pharma
Post# of 3
Posted On: 07/15/2014 10:27:11 PM
CAEH Financials 07/15/2014 21:27:14
Caleco Pharma Corp.
Period Ending Oct 31, 2010
Total Revenue -
Cost of Revenue -
Gross Profit -
Operating Expenses
Research and Development -
Sales, General and Admin. 849
Non-Recurring Items -
Other -
Operating Income 839
Income From Continuing Operations
Add'l Income/Expense Items (681)
Earnings Before Interest and Tax 1,554
Interest Expense 12
Earnings Before Tax 1,542
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations 1,542
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income 1,542
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders 1,542
Caleco Pharma Corp.
Period Ending Oct 31, 2010
Total Revenue -
Cost of Revenue -
Gross Profit -
Operating Expenses
Research and Development -
Sales, General and Admin. 849
Non-Recurring Items -
Other -
Operating Income 839
Income From Continuing Operations
Add'l Income/Expense Items (681)
Earnings Before Interest and Tax 1,554
Interest Expense 12
Earnings Before Tax 1,542
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations 1,542
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income 1,542
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders 1,542
(0)
(0)Caleco Pharma Corp. (CAEH) Stock Research Links
Scroll down for more posts ▼